Combined Hemoperfusion and Continuous Veno-Venous Hemofiltration for Carbamazepine Intoxication.


Journal

Blood purification
ISSN: 1421-9735
Titre abrégé: Blood Purif
Pays: Switzerland
ID NLM: 8402040

Informations de publication

Date de publication:
2022
Historique:
received: 10 08 2021
accepted: 23 10 2021
pubmed: 9 12 2021
medline: 15 9 2022
entrez: 8 12 2021
Statut: ppublish

Résumé

Carbamazepine (CBZ) is a widely used anticonvulsant with a low molecular weight that allows for extracorporeal removal of free drug by both dialytic and hemoperfusion techniques, particularly in a massive overdose where serum protein binding is saturated. This report presents a case of CBZ intoxication where we were able to compare the mass removal of CBZ using hemoperfusion, with the mass removal of CBZ achieved with continuous renal replacement therapy (CRRT) during combined treatment. The Jafron HA230 resin hemoperfusion cartridge was applied in series with the continuous veno-venous hemofiltration (CVVH) circuit. Baseline and ongoing serum drug levels along with further samples from pre- and post-hemoperfusion cartridges and from CVVH effluent were collected. Combined CVVH and resin hemoperfusion therapy in series was associated with a 50% reduction in the CBZ level from 16 mg/L to 8 mg/L over 3 h, far more rapid than that observed with CVVH alone or in the absence of extracorporeal drug clearance in the preceding hours. The combination therapy removed close to 35 mg/h of CBZ. The combination of CRRT and hemoperfusion can be easily deployed, appears safe, and is able to combine the CBZ mass removal achieved with each technique, thus to maximize CBZ extraction.

Identifiants

pubmed: 34879379
pii: 000520520
doi: 10.1159/000520520
doi:

Substances chimiques

Benzodiazepines 12794-10-4
Carbamazepine 33CM23913M

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

721-725

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Simon Baylis (S)

Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.

Rahul Costa-Pinto (R)

Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia, rahulcp@hotmail.com.
Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia, rahulcp@hotmail.com.

Sarah Hodgson (S)

Victorian Poisons Information Centre, Austin Hospital, Melbourne, Victoria, Australia.

Rinaldo Bellomo (R)

Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.
The Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Ian Baldwin (I)

Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH